Navidea Biopharmaceuticals, Inc. (NAVB) Financial Statements (2024 and earlier)

Company Profile

Business Address 4995 BRADENTON AVENUE
DUBLIN, OH 43017
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,995,8604,230,8652,670,4951,047,1593,475,8814,592,610
Cash and cash equivalents1,995,8604,230,8652,670,4951,047,1593,475,8812,795,006
Short-term investments      1,797,604
Inventory, net of allowances, customer advances and progress billings427,344151,155169,798  (748)
Inventory427,344151,155169,798  (748)
Other undisclosed current assets780,7401,001,2653,688,0351,868,6242,119,8759,240,543
Total current assets:3,203,9445,383,2856,528,3282,915,7835,595,75613,832,405
Noncurrent Assets
Operating lease, right-of-use asset20,300128,215250,095281,688
Property, plant and equipment135,347120,490132,16230,210162,172236,701
Intangible assets, net (including goodwill)1,000,241785,651620,241385,413428,492458,156
Intangible assets, net (excluding goodwill)1,000,241785,651620,241385,413428,492458,156
Other noncurrent assets11,774227,192227,192537,812835,1071,444,798
Other undisclosed noncurrent assets      4,809,376
Total noncurrent assets:1,167,6621,261,5481,229,6901,235,1231,425,7716,949,031
TOTAL ASSETS:4,371,6066,644,8337,758,0184,150,9067,021,52720,781,436
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 2,912,1952,656,9011,948,8452,050,6962,074,8311,789,776
Employee-related liabilities1,194,719755,494925,0091,637,337915,672
Accounts payable 2,122,5381,421,3171,161,7171,112,069424,718855,043
Accrued liabilities 789,65740,86531,63413,61812,77619,061
Deferred revenue800,000   
Debt 543,613453,427745,443556,508316,0742,353,639
Estimated litigation liability      2,887,566
Disposal group, including discontinued operation      7,092
Other undisclosed current liabilities5,686,0812,189,4742,020,8171,212,347987,6131,030,330
Total current liabilities:9,941,8895,299,8024,715,1053,819,5513,378,5188,068,403
Noncurrent Liabilities
Long-term debt and lease obligation:  20,288296,006512,344  
Liabilities, other than long-term debt2,573,027700,000700,000700,00064,05576,611
Deferred revenue700,000700,000700,000700,000
Due to related parties1,871,715     
Other liabilities     64,05576,611
Operating lease, liability1,31220,288296,006512,344
Other undisclosed noncurrent liabilities     1,168,494588,092
Total noncurrent liabilities:2,573,027720,288996,0061,212,3441,232,549664,703
Total liabilities:12,514,9166,020,0905,711,1115,031,8954,611,0678,733,106
Equity
Equity, attributable to parent, including:(8,435,828)(106,556)1,315,604(1,612,292)1,742,13911,379,630
Preferred stock, shares subscribed but unissued, subscriptions receivable   (10,300,000)   
Common stock 223,684221,277218,146210,232200,391162,207
Common stock, share subscribed but unissued, subscriptions receivable   (4,975,000)   
Common stock, value, subscriptions   995902  
Additional paid in capital379,343,124370,459,705375,428,014345,847,676338,265,383331,128,787
Accumulated other comprehensive loss     (730)(2,396)
Accumulated deficit(388,002,649)(370,787,610)(359,056,683)(347,671,102)(336,722,905)(319,908,968)
Other undisclosed equity, attributable to parent1372132   
Equity, attributable to noncontrolling interest292,518731,299731,303731,303668,321668,700
Total equity:(8,143,310)624,7432,046,907(880,989)2,410,46012,048,330
TOTAL LIABILITIES AND EQUITY:4,371,6066,644,8337,758,0184,150,9067,021,52720,781,436

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues65,652531,513915,013657,8261,169,3511,810,437
Sublease income    378,000
Cost of revenue(1,941) (1,048)(6,667)(96,636)(3,651)
Cost of goods and services sold (183,006)    (3,651)
Other undisclosed gross profit(183,006)     
Gross profit:(119,295)531,513913,965651,1591,072,7151,806,786
Operating expenses(13,931,600)(12,591,925)(11,625,146)(11,613,676)(11,920,016)(15,683,793)
Operating loss:(14,050,895)(12,060,412)(10,711,181)(10,962,517)(10,847,301)(13,877,007)
Nonoperating income (expense)(1,126,261)(20,476)(10,510)17,6751,145(33,339)
Investment income, nonoperating(1,098,322)(6,361)11,34425,288  
Other nonoperating income (expense)(27,939)(14,115)(21,854)(7,613)1,145(33,339)
Interest and debt expense(344,024)366,000(6,000)(8,000)(5,291,616)(4,201,668)
Loss from continuing operations before equity method investments, income taxes:(15,521,180)(11,714,888)(10,727,691)(10,952,842)(16,137,772)(18,112,014)
Other undisclosed income (loss) from continuing operations before income taxes344,024 6,0008,000(30,799)322,328
Loss from continuing operations before income taxes:(15,177,156)(11,714,888)(10,721,691)(10,944,842)(16,168,571)(17,789,686)
Income tax expense (benefit)  (16,043) (707)9,7534,062,489
Loss from continuing operations:(15,177,156)(11,730,931)(10,721,691)(10,945,549)(16,158,818)(13,727,197)
Loss before gain (loss) on sale of properties:(11,730,931)(10,721,691)(10,948,214)(16,158,818)(13,727,197)
Loss from discontinued operations    (2,665)  
Other undisclosed net income    44,50288,673,053
Net income (loss):(15,177,156)(11,730,931)(10,721,691)(10,948,214)(16,114,316)74,945,856
Net income attributable to noncontrolling interest34 17379210
Net income (loss) attributable to parent:(15,177,153)(11,730,927)(10,721,691)(10,948,197)(16,113,937)74,946,066
Preferred stock dividends and other adjustments(2,037,886) (663,889)   
Other undisclosed net loss available to common stockholders, basic      
Net income (loss) available to common stockholders, diluted:(17,215,039)(11,730,927)(11,385,580)(10,948,197)(16,113,937)74,946,066

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(15,177,156)(11,730,931)(10,721,691)(10,948,214)(16,114,316)74,945,856
Other undisclosed comprehensive income (loss)    7301,666(2,396)
Comprehensive income (loss):(15,177,156)(11,730,931)(10,721,691)(10,947,484)(16,112,650)74,943,460
Comprehensive income, net of tax, attributable to noncontrolling interest34 17379210
Comprehensive income (loss), net of tax, attributable to parent:(15,177,153)(11,730,927)(10,721,691)(10,947,467)(16,112,271)74,943,670

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: